ReviewMolecules (Basel, Switzerland)2026
Advances in Nuclear Medicine Diagnostics: The Promise of Radiolabeled Dendrimers.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
One of the most widespread causes of mortality is cancer, and its early diagnosis is a key element of modern medicine. A crucial role is played by imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and computed tomography (CT), which require the use of appropriate radioactive isotope tracers to enable precise visualization of pathological changes. In recent years, hyperbranched dendrimers have attracted considerable attention due to their unique architecture and functionalization capacity, making them a promising platform for the delivery of radiotracers. The aim of this manuscript is to provide an overview of radiolabeled dendrimer conjugates, their functionalization methods, and the results of preclinical studies confirming their diagnostic potential. It pays particular attention to the stability and radiochemical purity of the systems, and their ability to overcome physiological barriers. The findings presented indicate that dendrimer-based radiotracers constitute a promising class of carriers for diagnostic imaging, although further studies are required to optimize their physicochemical and biological properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.